Accumulation of iron oxide nanoparticles by cultured brain astrocytes

Journal of Biomedical Nanotechnology

Volumn 5, Issue 3, 2009, Pages 285-293

  Geppert, Mark ^a   Hohnholt, Michaela ^a   Gaetjen, Linda ^b   Grunwald, Ingo ^b   Bäumer, Marcus ^a   Dringen, Ralf ^a,c  

^a UNIVERSITY OF BREMEN   (Germany)

^b FRAUNHOFER INSTITUTE FOR MANUFACTURING TECHNOLOGY AND ADVANCED MATERIALS IFAM   (Germany)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Accumulation; Astrocytes; Brain; Iron; Nanoparticles; Oxidative stress; Uptake

Indexed keywords

ACCUMULATION; ASTROCYTES; BRAIN CELLS; CONTRAST AGENT; FERRIC AMMONIUM CITRATE; FERROUS IRON; IN-CELL; INCUBATION TEMPERATURES; IRON ACCUMULATION; IRON COMPLEX; IRON CONTENT; IRON OXIDE NANOPARTICLE; LOW MOLECULAR WEIGHT; MAGNETIC DRUG DELIVERY; MAGNETIC IRON OXIDE NANOPARTICLES; MODEL SYSTEM; PRIMARY CULTURE; THERAPEUTIC APPLICATION; UPTAKE;

AMMONIUM COMPOUNDS; BIOCOMPATIBILITY; CELL CULTURE; CELL MEMBRANES; DRUG DELIVERY; IRON; MAGNETIC RESONANCE IMAGING; NANOPARTICLES; TRANSMISSION ELECTRON MICROSCOPY;

IRON OXIDES;

CITRIC ACID; FERRIC AMMONIUM CITRATE; IRON; IRON OXIDE; NANOPARTICLE;

ANIMAL EXPERIMENT; ARTICLE; ASTROCYTE; BIOCOMPATIBILITY; BRAIN CELL; BRAIN NERVE CELL; CELL VIABILITY; NEWBORN; NONHUMAN; RAT; SYNTHESIS; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; BRAIN; BRAIN CHEMISTRY; CELLS, CULTURED; FERRIC COMPOUNDS; NANOPARTICLES; RATS; RATS, WISTAR;

EID: 69249164826     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2009.1033     Document Type: Article

References (47)

1. S. Laurent, D. Forge, M. Port, A. Roch, C. Robic, L. V. Elst, and R. N. Muller, Magnetic iron oxide nanoparticles: Synthesis, stabilization, vectorization, physicochemical characterizations and biological applications. Chem. Rev. 108, 2064 (2008).
2. J. Kreuter, Application of nanoparticles for the delivery of drugs to the brain. Int. Congr. Ser. 1277, 85 (2005).
3. C. Corot, P. Robert, J. M. Idée, and M. Port, Recent advances in iron oxide nanocrystal technology for medical imaging, Adv. Drug Deliv. Rev. 58, 1471 (2006).
4. 4-nanoparticles: Low toxicity and rapid heating for thermal therapy, J. Mater. Chem. 18, 1204 (2008).
5. F. Schüth, A. H. Lu, and E. L. Salabas, Magnetische nanopartikel: Synthese, Stabilisierung, funktionalisierung und anwendung. Angew. Chem. 119, 1242(2007).
6. A. Bee, R. Massart, and S. Neveu, Synthesis of very fine maghemite particles. J. Magn. Magn. Mater. 149, 6 (1995).
7. S. Sun, H. Zeng, Size-controlled synthesis of magnetite nanoparticles. J. Am. Chem. Soc. 124, 8204 (2002).
8. I. Markiewicz and B. Lukomska, The role of astrocytes in the physiology and pathology of the central nervous system. Acta Neurobiol. Exp. 66, 343 (2006).
9. M. Nedergaard, B. Ransom, and S. A. Goldman, New roles for astrocytes: Redefining the functional architecture of the brain. Trends Neurosci. 26, 532 (2003).
10. F. Kirchhoff, R. Dringen, and C. Giaume, Pathways of neuron-astrocyte interactions and their possible role in neuroprotection. Eur. Arch. Psychiatr. Clin. Neurosci. 251, 159 (2001).
11. E. E. Benarroch, Neuron-astrocyte interactions: Partnership for normal function and disease in the central nervous system. Mayo Clin. Pmc. 80, 1326 (2005).
12. A. J. L. Cooper, The Role of Glutathione in the Nervous System, edited by C. A. Shaw, Taylor and Francis, Washington (1998), pp. 91-115.
13. R. Dringen, P. G. Pawlowski, and J. Hirrlinger, Peroxide detoxification by brain cells. J. Neurosci. Res. 79, 157 (2005).
14. R. Dringen, The New Encyclopedia of Neuroscience, edited by L. Squire, T. Albright, F. Bloom, F. Gage, and N. Spitzer, Elsevier, Oxford (2009), pp. 733-737.
15. E. Tiffany-Castiglioni and Y. Qian, Astroglia as metal depots: Molecular mechanisms for metal accumulation, storage and release, Neurotoxicology 22, 577 (2001).
16. R. Dringen, G. M. Bishop, M. Koeppe, T. N. Dang, and S. R. Robinson, The pivotal role of astrocytes in the metabolism of iron in the brain, Neurochem. Res. 32, 1884 (2007).
17. T. Moos, T. Rosengren Nielsen, T. Skjørringe, and E. H. Morgan, Iron trafficking inside the brain. J. Neurochem. 103, 1730 (2007).
18. C. Au, L. Mutkus, A. Dobson, J. Riffle, J. Lalli, and M. Aschner, Effects of nanoparticles on the adhesion and cell viability on astrocytes. Biol. Trace Elem. Res. 120, 248 (2007).
19. T. R. Pisanic II, J. D. Blackwell, V. I. Shubayev, R. R. Finones, and S. Jin, Nanotoxicity of iron oxide nanoparticles internalization in growing neurons. Biomaterials 28, 2572 (2007).
20. B. Hamprecht and F. Löffler, Primary glial cultures as model for studying hormone action, Methods Enzymol. 109, 341 (1985).
21. J. Riemer, H. H. Hoepken, H. Czerwinska, S. R. Robinson, and R. Dringen, Colorimetric ferrozine-based assay for the quantification of iron in cultured cells. Anal. Biochem. 331, 370 (2004).
22. G. M. Bishop and S. R. Robinson, Quantitative analysis of cell death and ferritin expression in response to cortical iron: Implications for hypoxia-ischemia and stroke, Brain Res. 907, 175 (2001).
23. T. Moos and K. Mollgrad, A sensitive post-DAB enhancement technique for demonstration of iron in the central nervous system. Histochemistry 99, 471 (1993).
24. M. Grusch, D. Polgar, S. Gfatter, K. Leuhuber, S. Huettenbrenner, C. Leisser, G. Fuhrmann, F. Kassie, H. Steinkellner, K. Smid, G. J. Peters, H. N. Jayaram, W. Klepal, T. Szekeres, S. Knasmüller, and G. Krupitza, Maintenance of ATP favours apoptosis over necrosis triggered by benzamide riboside. Cell Death Differ. 9, 169 (2002).
25. R. Dringen, L. Kussmaul, and B. Hamprecht, Detoxification of endogenous hydrogen peroxide and organic hydroperoxides by cultured astroglia cells assessed by microtiter plate assay. Brain Res. Protoc. 2, 223 (1998).
26. O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall, Protein measurements with the Folin phenol reagent. J. Biol. Chem. 193, 265 (1951).
27. D. Maity and D. C. Agrawal, Synthesis of iron oxide nanoparticles under oxidizing environment and their stabilization in aqueous and non-aqueous media. J. Magn. Magn. Mater. 308, 46 (2007).
28. A. K. Gupta and M. Gupta, Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 26, 3995 (2005).
29. N. Fauconnier, J. N. Pons, J. Roger, and A. Bee, Thiolation of maghemite nanoparticles by dimercaptosuccinic acid. J. Colloid Interface Sci. 194, 427 (1997).
30. N. Fauconnier, A. Bee, J. Roger, and J. N. Pons, Synthesis of aqueous magnetic liquids by surface complexation of maghemite nanoparticles. J. Mol. Liq. 83, 233 (1999).
31. H. Pilgrimm, Superparamagnetic particles with increased R1 relaxivity, process for producing said particles and use thereof. U.S. Patent 6,634,494, October (2003).
32. A. Petri-Fink, B. Steitz, A. Finka, J. Salaklang, and H. Hofmann, Effect of cell media on polymer coated superparamagnetic iron oxide nanoparticles (SPIONs): Colloidal stability, cytotoxicity, and cellular uptake studies. Eur. J. Pharm. Biopharm. 86, 129 (2008).
33. N. Westergaard, U. Sonnewald, G. Unsgard, L. Peng, L. Hertz, and A. Schousboe, Uptake, release, and metabolism of citrate in neurons and astrocytes in primary cultures. J. Neurochem. 62, 1727 (1994).
34. H. H. Hoepken, T. Korten, S. R. Robinson, and R. Dringen, Iron accumulation, iron-mediated toxicity and altered levels of ferritin and transferrin receptor in cultured astrocytes during incubation with ferric ammonium citrate. J. Neurochem. 88, 1194 (2004).
35. A. Naveau, P. Smirnov, C. Ménager, F. Gazeau, O. Clément, A. Lafont, and B. Gogly, Phenotypic study of human gingival fibroplasts labeled with superparamagnetic anionic nanoparticles. J. Periodontal. 77, 238 (2006).
36. M. F. Falangola, S. P. Lee, R. A. Nixon, K. Duff, and J. A. Helpem, Histological co-localization of iron in Aβ plaques of PS/APP transgenic mice. Neurochem. Res. 30, 201 (2005).
37. J. R. Burdo, J. Martin, S. L. Menzies, K. G. Dolan, M. A. Romano, R. J. Fletcher, M. D. Garrick, L. M. Garrick, and J. R. Connor, Cellular distribution of iron in the brain of the Belgrade rat. Neuroscience 93, 1189 (1999).
38. D. J. Piñero and J. R. Connor, Iron in the brain: An important contributor in normal and diseased states. Neuroscientist 6, 435 (2000).
39. D. Trinder and E. Morgan, Mechanisms of ferric citrate uptake by human hepatoma cells. Am. J. Physiol. Gastrointest. Liver. Physiol. 275, 279 (1998).
40. Z. M. Qian, Q. K. Liao, Y. To, Y. Ke, Y. K. Tsoi, G. F. Wang, and K. P. Ho, Transferrin-bound and transferrin free iron uptake by cultured rat astrocytes. Cell. Mol. Biol. 46, 541 (2000).
41. D. R. Richardson, Iron and gallium increase iron uptake from transferrin by human melanoma cells: Further examination of the ferric ammonium citrate-derived iron uptake process, Biochim. Biophys. Acta 1536, 43 (2001).
42. M. Arreedondo, J. Kloosterman, S. Núñez, F. Segovia, V. Candia, S. Flores, S. Le Blanc, M. Olivares, and F. Pizarro, Heme iron uptake by Caco-2 cells is a saturable, temperature sensitive and modulated by extracellular pH and potassium. Biol. Trace Elem. Res. 125, 109 (2008).
43. J. S. Kim, T. J. Yoon, K. N. Yu, M. S. Noh, M. Woo, B. G. Kim, K. H. Lee, B. H. Sohn, S. B. Park, J. K. Lee, and M. H. Cho, Cellular uptake of magnetic nanoparticles is mediated through energy-dependent endocytosis in A549 cells. J. Vet. Sci. 7, 321 (2006).
44. A. Petri-Fink and H. Hoffmann, Superparamagnetic iron oxide nanoparticles (SPIONs): From synthesis to in vivo studies - a summary of the synthesis, characterization, in vitro and in vivo investigations of SPIONs with particular focus on surface and colloidal properties. IEEE Transact. Nanobiosci. 6, 289 (2007).
45. J. R. Liddell, H. H. Hoepken, P. J. Crack, S. R. Robinson, and R. Dringen, Glutathione peroxidase 1 and glutathione are required to protect mouse astrocytes from iron-mediated hydrogen peroxide toxicity. J. Neurosci. Res. 84, 578 (2006).
46. J. R. Liddell, S. R. Robinson, and R. Dringen, Endogenous glutathione and catalase protect cultured rat astrocytes from the iron-mediated toxicity of hydrogen peroxide. Neurosci. Lett. 364, 164 (2004).
47. A. Nel, T. Xia, L. Mädler, and L. Ning, Toxic potential of materials at the nanolevel. Science 311, 622 (2006).